These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5727873)

  • 21. [Oral galactose tolerance test. Diagnostic criteria and biological deviation in healthy persons and patients with liver diseases].
    Rommel K; Grimmel K
    Med Klin; 1966 Nov; 61(44):1735-8. PubMed ID: 5989738
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
    Järnerot G
    Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422
    [No Abstract]   [Full Text] [Related]  

  • 23. [Galactose tolerance test and double glaucagon test].
    Verhaegen H; De Beukelaar A; Krug F; Verhaegen-Declercq ML
    Tijdschr Gastroenterol; 1970; 13(5):380-7. PubMed ID: 5512730
    [No Abstract]   [Full Text] [Related]  

  • 24. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on galactose tolerance test in patients with liver disease.
    Kikuchi S; Kato K; Shiga O; Oya T; Ito M
    Nagoya J Med Sci; 1972 Aug; 35(1):19-24. PubMed ID: 4665967
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions.
    Kesäniemi YA; Kurppa KO; Salaspuro MP
    Scand J Gastroenterol; 1973; 8(7):593-8. PubMed ID: 4768306
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions.
    Salaspuro MP; Kesäniemi YA
    Scand J Gastroenterol; 1973; 8(7):681-6. PubMed ID: 4768313
    [No Abstract]   [Full Text] [Related]  

  • 29. [Re-evaluation of galactose tolerance test in clinical diagnosis].
    Kaneda E; Nagai S; Misugi Y; Yamaguchi H; Nakano Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):158. PubMed ID: 4475767
    [No Abstract]   [Full Text] [Related]  

  • 30. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Galactose test in the diagnosis of chronic liver diseases, particularly cirrhoses].
    Fassati P; Fassati M
    Cesk Gastroenterol Vyz; 1967 Jul; 21(5):289-93. PubMed ID: 6062313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of hepatic function by galactose and bromosulfophthalein: their reciprocal interference].
    Spandri P; Dal Palù C; Zuin R
    Sem Hop; 1967 Sep; 43(38):2304-8. PubMed ID: 4294090
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of liver function in endemic nephropathy].
    Milev B
    Z Gesamte Inn Med; 1972 Jul; 27(14):601-5. PubMed ID: 5082874
    [No Abstract]   [Full Text] [Related]  

  • 35. [Simultaneous bromsulfalein and galactose loading as a liver function test].
    Nilsson LH; Hultman E
    Nord Med; 1971 Aug; 85(31):942-3. PubMed ID: 5569721
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
    Järnerot G
    Nord Med; 1971 Mar; 85(11):351-2. PubMed ID: 5553213
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
    Tygstrup N; Vilstrup H
    Lab Res Methods Biol Med; 1983; 7():17-41. PubMed ID: 6353103
    [No Abstract]   [Full Text] [Related]  

  • 38. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parenchymatous liver functional examination. Contribution of the intravenous galactose clearance test. Study with multidimensional statistical analyses].
    Hecht Y; Benamar A; Touboul JP; el-Guedri H; Nakache JP; Salmon D
    Med Chir Dig; 1973; 2(2):81-90. PubMed ID: 4743211
    [No Abstract]   [Full Text] [Related]  

  • 40. [WF test for the study of the absorptive-excretory function of the liver].
    Loginov AS; Kondashova ZD
    Ter Arkh; 1970 Jun; 42(6):101-3. PubMed ID: 4099424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.